CN111387483A - 一种用于高尿酸血症和痛风患者的医用营养粉及制备方法 - Google Patents
一种用于高尿酸血症和痛风患者的医用营养粉及制备方法 Download PDFInfo
- Publication number
- CN111387483A CN111387483A CN202010046666.6A CN202010046666A CN111387483A CN 111387483 A CN111387483 A CN 111387483A CN 202010046666 A CN202010046666 A CN 202010046666A CN 111387483 A CN111387483 A CN 111387483A
- Authority
- CN
- China
- Prior art keywords
- parts
- premix
- vitamin
- powder
- hyperuricemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000843 powder Substances 0.000 title claims abstract description 64
- 201000001431 Hyperuricemia Diseases 0.000 title claims abstract description 41
- 201000005569 Gout Diseases 0.000 title claims abstract description 40
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 32
- 230000035764 nutrition Effects 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 239000000126 substance Substances 0.000 claims abstract description 48
- 239000000463 material Substances 0.000 claims abstract description 33
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 29
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 29
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 16
- 235000010755 mineral Nutrition 0.000 claims abstract description 16
- 239000011707 mineral Substances 0.000 claims abstract description 16
- 235000018102 proteins Nutrition 0.000 claims abstract description 16
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 16
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 16
- 239000002562 thickening agent Substances 0.000 claims abstract description 16
- 229940088594 vitamin Drugs 0.000 claims abstract description 16
- 229930003231 vitamin Natural products 0.000 claims abstract description 16
- 235000013343 vitamin Nutrition 0.000 claims abstract description 16
- 239000011782 vitamin Substances 0.000 claims abstract description 16
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 11
- 108010011485 Aspartame Proteins 0.000 claims abstract description 11
- 235000009499 Vanilla fragrans Nutrition 0.000 claims abstract description 11
- 235000012036 Vanilla tahitensis Nutrition 0.000 claims abstract description 11
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims abstract description 11
- 229960003438 aspartame Drugs 0.000 claims abstract description 11
- 235000010357 aspartame Nutrition 0.000 claims abstract description 11
- 239000000605 aspartame Substances 0.000 claims abstract description 11
- 229960003080 taurine Drugs 0.000 claims abstract description 11
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 11
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 7
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 7
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 7
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 7
- 235000021119 whey protein Nutrition 0.000 claims abstract description 7
- 241000283690 Bos taurus Species 0.000 claims abstract description 6
- 210000003022 colostrum Anatomy 0.000 claims abstract description 6
- 235000021277 colostrum Nutrition 0.000 claims abstract description 6
- 235000008939 whole milk Nutrition 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims description 45
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 37
- 238000002156 mixing Methods 0.000 claims description 31
- 238000001035 drying Methods 0.000 claims description 15
- 239000002245 particle Substances 0.000 claims description 15
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 15
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 10
- 244000290333 Vanilla fragrans Species 0.000 claims description 10
- 238000009826 distribution Methods 0.000 claims description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 10
- 238000005469 granulation Methods 0.000 claims description 10
- 230000003179 granulation Effects 0.000 claims description 10
- 235000019197 fats Nutrition 0.000 claims description 9
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 8
- 239000000194 fatty acid Substances 0.000 claims description 8
- 229930195729 fatty acid Natural products 0.000 claims description 8
- 238000005507 spraying Methods 0.000 claims description 8
- -1 fatty acid esters Chemical class 0.000 claims description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 5
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 5
- 235000019743 Choline chloride Nutrition 0.000 claims description 5
- 239000011665 D-biotin Substances 0.000 claims description 5
- 235000000638 D-biotin Nutrition 0.000 claims description 5
- 229920001353 Dextrin Polymers 0.000 claims description 5
- 239000004375 Dextrin Substances 0.000 claims description 5
- 229920002907 Guar gum Polymers 0.000 claims description 5
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 5
- 229920001202 Inulin Polymers 0.000 claims description 5
- 239000005913 Maltodextrin Substances 0.000 claims description 5
- 229920002774 Maltodextrin Polymers 0.000 claims description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 5
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 5
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 5
- 235000010489 acacia gum Nutrition 0.000 claims description 5
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 5
- 239000000853 adhesive Substances 0.000 claims description 5
- 230000001070 adhesive effect Effects 0.000 claims description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 5
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 5
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 5
- 239000001354 calcium citrate Substances 0.000 claims description 5
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 claims description 5
- 239000000679 carrageenan Substances 0.000 claims description 5
- 235000010418 carrageenan Nutrition 0.000 claims description 5
- 229920001525 carrageenan Polymers 0.000 claims description 5
- 229940113118 carrageenan Drugs 0.000 claims description 5
- 229960003178 choline chloride Drugs 0.000 claims description 5
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 5
- 239000003240 coconut oil Substances 0.000 claims description 5
- 235000019864 coconut oil Nutrition 0.000 claims description 5
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 5
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 5
- 235000019425 dextrin Nutrition 0.000 claims description 5
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 5
- 239000004222 ferrous gluconate Substances 0.000 claims description 5
- 235000013924 ferrous gluconate Nutrition 0.000 claims description 5
- 229960001645 ferrous gluconate Drugs 0.000 claims description 5
- 229960000304 folic acid Drugs 0.000 claims description 5
- 235000019152 folic acid Nutrition 0.000 claims description 5
- 239000011724 folic acid Substances 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 239000000665 guar gum Substances 0.000 claims description 5
- 235000010417 guar gum Nutrition 0.000 claims description 5
- 229960002154 guar gum Drugs 0.000 claims description 5
- 229960000367 inositol Drugs 0.000 claims description 5
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 5
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 5
- 229940029339 inulin Drugs 0.000 claims description 5
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 claims description 5
- 239000001755 magnesium gluconate Substances 0.000 claims description 5
- 235000015778 magnesium gluconate Nutrition 0.000 claims description 5
- 229960003035 magnesium gluconate Drugs 0.000 claims description 5
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 claims description 5
- 229940035034 maltodextrin Drugs 0.000 claims description 5
- 239000011683 manganese gluconate Substances 0.000 claims description 5
- 235000014012 manganese gluconate Nutrition 0.000 claims description 5
- 229940072543 manganese gluconate Drugs 0.000 claims description 5
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 claims description 5
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 5
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 5
- 239000004006 olive oil Substances 0.000 claims description 5
- 235000008390 olive oil Nutrition 0.000 claims description 5
- 239000011772 phylloquinone Substances 0.000 claims description 5
- 239000004224 potassium gluconate Substances 0.000 claims description 5
- 235000013926 potassium gluconate Nutrition 0.000 claims description 5
- 229960003189 potassium gluconate Drugs 0.000 claims description 5
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 5
- 239000002002 slurry Substances 0.000 claims description 5
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 5
- 229960005055 sodium ascorbate Drugs 0.000 claims description 5
- 235000010378 sodium ascorbate Nutrition 0.000 claims description 5
- 239000001509 sodium citrate Substances 0.000 claims description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 5
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 5
- 239000011781 sodium selenite Substances 0.000 claims description 5
- 235000015921 sodium selenite Nutrition 0.000 claims description 5
- 229960001471 sodium selenite Drugs 0.000 claims description 5
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 5
- 239000007779 soft material Substances 0.000 claims description 5
- 239000003549 soybean oil Substances 0.000 claims description 5
- 235000012424 soybean oil Nutrition 0.000 claims description 5
- 238000003892 spreading Methods 0.000 claims description 5
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 5
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- 239000011691 vitamin B1 Substances 0.000 claims description 5
- 239000011715 vitamin B12 Substances 0.000 claims description 5
- 239000011716 vitamin B2 Substances 0.000 claims description 5
- 239000011726 vitamin B6 Substances 0.000 claims description 5
- 239000011647 vitamin D3 Substances 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- 229940045997 vitamin a Drugs 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 238000005550 wet granulation Methods 0.000 claims description 5
- 239000011670 zinc gluconate Substances 0.000 claims description 5
- 235000011478 zinc gluconate Nutrition 0.000 claims description 5
- 229960000306 zinc gluconate Drugs 0.000 claims description 5
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 5
- 239000006185 dispersion Substances 0.000 claims description 4
- 239000001335 perilla frutescens leaf extract Substances 0.000 claims description 2
- 235000013305 food Nutrition 0.000 abstract description 6
- 235000019577 caloric intake Nutrition 0.000 abstract description 2
- 235000021062 nutrient metabolism Nutrition 0.000 abstract description 2
- 244000263375 Vanilla tahitensis Species 0.000 abstract 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 18
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 16
- 229940116269 uric acid Drugs 0.000 description 16
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000004347 Perilla Nutrition 0.000 description 3
- 244000124853 Perilla frutescens Species 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000029142 excretion Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010018634 Gouty Arthritis Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102000011931 Nucleoproteins Human genes 0.000 description 2
- 108010061100 Nucleoproteins Proteins 0.000 description 2
- 206010046337 Urate nephropathy Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 235000021120 animal protein Nutrition 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000021196 dietary intervention Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- NAFSTSRULRIERK-UHFFFAOYSA-M monosodium urate Chemical group [Na+].N1C([O-])=NC(=O)C2=C1NC(=O)N2 NAFSTSRULRIERK-UHFFFAOYSA-M 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 208000016839 purine metabolism disease Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/238—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Pediatric Medicine (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明公开了一种用于高尿酸血症和痛风患者的医用营养粉及制备方法,涉及医用食品技术领域,包含如下重量份的组份:蛋白质类物质71.9‑575份、脂肪类物质54‑433份、碳水化合物268‑2145份、矿物质14.2‑114份、维生素类物质4‑35份、牛磺酸0.4‑3.2份、0.5‑4份、左旋肉碱0.06‑0.49份、增稠剂10‑72份、香草香精1‑8份、阿斯巴甜0.28‑2.2份;所述的蛋白质类物质包括乳清蛋白粉35‑280份、大豆分离蛋白30‑280份、全脂奶粉35‑275份、牛初乳0.4‑4.0份。本发明提供的一种用于高尿酸血症和痛风患者的医用营养粉,每100g营养粉可供能1500‑1700kJ,按照指导方法服用可限制总能量摄入,维持理想体重,且蛋白质:脂肪:碳水化合物的供能比约为15%:25%:60%,符合高尿酸血症及痛风病人的营养代谢特点。
Description
技术领域
本发明涉及医用食品技术领域,具体为一种用于高尿酸血症和痛风患者的医用营养粉及制备方法。
背景技术
医用食品全称特殊医学用途配方食品(foods for special medical purposes,FSMP),是为了满足进食受限、消化吸收障碍、代谢紊乱或特定疾病状态人群对营养素或膳食的特殊需要,专门加工配制而成的配方食品。该类产品必须在医生或临床营养师指导下,单独食用或与其他食品配合食用。
高尿酸血症是以体内嘌呤代谢紊乱、尿酸生成增加及(或)尿酸排泄减少,使得尿酸在体内沉积为特征的疾病,严重时可造成病理生理的改变,引发痛风和尿酸性肾病等。因内源性嘌呤代谢产生的尿酸水平基本恒定,故体内尿酸水平主要受外界摄入富含嘌呤或核酸蛋白食物的影响。我国诊断标准为男性血尿酸﹥417μmol/L(7.0mg/ml),女性血尿酸﹥357μmol/L(6.0mg/ml)时则称为高尿酸血症。
痛风是单钠尿酸盐沉积于骨关节、肾脏和皮下等部位,引发的急、慢性炎症和组织损伤,与嘌呤代谢紊乱及(或)尿酸排泄减少所致的高尿酸血症直接相关,属于代谢性风湿病范畴。其临床特点是由高尿酸血症、尿酸盐沉积所导致的反复发作的急、慢性关节炎和软组织损伤,尿酸性肾结石所导致的痛风性肾病。痛风发病的关键生化基础是高尿酸血症,研究表明约有5%-10%的高尿酸血症会发展为痛风,且沿海、发达地区痛风患病率高于内陆地区,男性高于女性。
现今伴随经济的发展,高尿酸血症和痛风的患病率具有逐年上升的趋势,2016年日本在对痛风与高尿酸血症的发病率与患病率进行调查的过程中,发现高尿酸血症患病率男性为5.78%,女性为2.43%。根据《临床合理用药指南》的数据显示,2016年高尿素血症的发病率为4.71%,患病率为7.32%,2017年高尿酸血症的发病率为5.61%,患病率为9.32%,美国调查数据显示2016年高尿素血症的发病率为3.12%,患病率为4.61%,2017年高尿酸血症的发病率为6.47%,患病率为10.32%。
目前不仅是高尿酸血症和痛风的患病率在逐年上升,患病年龄也趋于年轻化,应该引起人们的关注。在痛风的各种诱发因素中,饮食因素占首位,因此通过合理膳食营养干预来缓解高尿酸血症和痛风患者的临床症状,保障机体营养、提高患者生活质量,所以亟需一种针对于高尿酸血症和痛风患者的营养粉。
发明内容
本发明的目的在于提供一种用于高尿酸血症和痛风患者的医用营养粉及制备方法。
为实现上述目的,本发明提供如下技术方案:
一种用于高尿酸血症和痛风患者的医用营养粉,包含如下重量份的组份:蛋白质类物质71.9-575份、脂肪类物质54-433份、碳水化合物268-2145份、矿物质14.2-114份、维生素类物质4-35份、牛磺酸0.4-3.2份、0.5-4份、左旋肉碱0.06-0.49份、增稠剂10-72份、香草香精1-8份、阿斯巴甜0.28-2.2份;
所述的蛋白质类物质包括乳清蛋白粉35-280份、大豆分离蛋白30-280份、全脂奶粉35-275份、牛初乳0.4-4.0份。
进一步的,所述的脂肪类物质包括紫苏籽油粉5-35份、椰子油粉19-152份、大豆油粉50-400份、橄榄油粉20-155份、中链甘油三酯粉1.5-12份。
进一步的,所述碳水化合物包括麦芽糊精155-1240份、菊粉15-120份、抗性糊精50-400份。
进一步的,所述的维生素类物质包括维生素A0.03-0.24份、维生素D30.02-0.16份、维生素E0.05-0.37份、维生素K10.004-0.032份、维生素B10.005-0.044份、维生素B20.006-0.04份、维生素B60.005-0.045份、维生素B120.001-0.009份、抗坏血酸钠0.74-5.8份、D-泛酸钙0.016-0.13份、叶酸0.001-0.008份、烟酰胺0.01-0.09份、氯化胆碱2.5-20份、D-生物素0.005-0.036份、肌醇1.65-13.2份。
进一步的,所述的矿物质包括柠檬酸钙5-40份、L-乳酸钙4-45份、磷酸二氢钠5-40份、柠檬酸钠15-120份、葡萄糖酸镁11.5-93份、葡萄糖酸亚铁0.2-1.6份、葡萄糖酸锌0.25-1.96份、葡萄糖酸钾22.5-180份、亚硒酸钠0.0006-0.005份、碘化钾0.0004-0.0035份、无水硫酸铜0.013-0.1份、葡萄糖酸锰0.06-0.5份。
进一步的,所述的增稠剂包括卡拉胶3-24份、瓜尔胶3.5-29份、阿拉伯胶2.5-20份。
一种用于高尿酸血症和痛风患者的医用营养粉的制备方法,包括以下步骤:
(1)准确称量原辅料
预混料a:包括上述的全部蛋白质类物质和部分碳水化合物;
预混料b:包括另一部分碳水化合物和全部矿物质;
预混料c:包括上述全部的脂肪类物质、单双甘油脂肪酸酯和增稠剂;
预混料d:包括剩余的碳水化合物、香草香精、阿斯巴甜、牛磺酸、左旋肉碱和全部维生素类物质;
(2)预混料a、b
将预混料a的原辅料转移至槽型混合机进行混合,搅拌时间为50-80min,得到预混料a;将预混料b的原辅料转移至方锥形混合机的混料斗中混合,调节转速为20-30r/min,最高/最低频率为50/5HZ,时间为50-80min,得到预混料b;然后再将预混料a、b投入槽型混合机中,反向搅拌50-80min,取出备用;
(3)制粒
使用高效湿法制粒机制软材,打开搅拌开关,调节转速为20-30r/min,搅拌5-30min;然后向预混料a、b中加入适量40%酒精粘合剂溶液,边搅拌边加浆。转速设置采用分段式,先设置搅拌速度为10-30r/min,分散速度10-30r/min,加入部分酒精,喷加酒精的频率为2-8s/次,每次约喷加酒精10~20g,间隔5-10s,加入后搅拌5-15min;其次设置搅拌速度为20-50r/min,分散速度20-50r/min,再加入部分酒精,加入后搅拌5-15min;最后加入剩余的酒精,加入后搅拌5-15min,三次添加酒精的比例为2:3:1;
然后取100g样品过40目、80目和100目筛网查看颗粒分布,分布合适即可出料;
(4)干燥整粒
将湿颗粒均匀铺于烘盘中,然后置于60℃烘箱内进行烘干,当品水分至5%左右停止烘干,关闭烘箱开关,取出样品;
(5)预混料c、d
将预混料c的原辅料、和预混料d的原辅料投入混料斗中进行预混,设置转速30-50r/min,时间为50-80min,得到预混料c和预混料d;
(6)总混
称取与制粒样品等比例的预混料c、d倒入三维混合机中,再投入制粒样品,设置转速30-50r/min,混合100-150min,得到成品。
与现有技术相比,本发明的有益效果是:本发明提供的一种用于高尿酸血症和痛风患者的医用营养粉,每100g营养粉可供能1500-1700kJ,按照指导方法服用可限制总能量摄入,维持理想体重,且蛋白质:脂肪:碳水化合物的供能比约为15%:25%:60%,符合高尿酸血症及痛风病人的营养代谢特点。蛋白质含量较成年人营养需求有所降低,动植物蛋白配比合理,其中乳清蛋白和大豆分离蛋白在满足机体正常蛋白质需求的同时不增加外源性核蛋白,可减少外源性嘌呤的摄入,减轻血清尿酸的负荷。本发明碳水化合物含量较高,且不含果糖,能够防止脂肪分解产生酮体,促进尿酸的排出。维生素C具有助于降低首次痛风性关节炎患者血尿酸及尿尿酸水平,降低痛风性关节炎的复发率,改善远期预后。B族维生素以及铁、锌等营养素,可使尿液呈碱性,有利于尿酸盐溶解,加速尿酸排泄,防止结石形成。
本发明提供的一种用于高尿酸血症和痛风患者的医用营养粉,针对高尿酸血症和痛风的营养需求,以不含核蛋白的动物蛋白和植物蛋白等为原料,特别添加丰富的B族维生素和维生素C等营养素,经科学配伍,在提供充足营养的同时,减缓血清尿酸水平升高,促进尿酸排出。本发明产品无任何毒副作用,旨在通过饮食减轻高尿酸血症及痛风患者的病发程度,提高治疗效率,促进并维持机体适宜的营养状态,改善患者的生活质量。
具体实施方式
下面对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1:
一种用于高尿酸血症和痛风患者的医用营养粉,包含如下重量份的组份:蛋白质类物质115份、脂肪类物质87份、碳水化合物430份、矿物质22.7份、维生素类物质7份、牛磺酸0.7份、单双甘油脂肪酸酯0.8份、左旋肉碱0.01份、增稠剂15份、香草香精1.8份、阿斯巴甜0.44份;
所述的蛋白质类物质包括乳清蛋白粉56份、大豆分离蛋白56份、全脂奶粉60份、牛初乳0.8份。
所述的脂肪类物质包括紫苏油粉7份、椰子油粉30.5份、大豆油粉80份、橄榄油粉30份、中链甘油三酯粉2.4份。
所述碳水化合物包括麦芽糊精248份、菊粉24份、抗性糊精80份。
所述的维生素类物质包括维生素A 0.048份、维生素D3 0.032份、维生素E 0.08份、维生素K1 0.008份、维生素B1 0.009份、维生素B2 0.01份、维生素B6 0.01份、维生素B120.02份、抗坏血酸钠0.2份、D-泛酸钙0.025份、叶酸0.0016份、烟酰胺0.02份、氯化胆碱4.2份、D-生物素0.008份、肌醇2.65份。
所述的矿物质包括柠檬酸钙8份、L-乳酸钙9.2份、磷酸二氢钠8.5份、柠檬酸钠24份、葡萄糖酸镁18.4份、葡萄糖酸亚铁0.5份、葡萄糖酸锌0.5份、葡萄糖酸钾36份、亚硒酸钠0.001份、碘化钾0.0006份、无水硫酸铜0.02份、葡萄糖酸锰0.15份。
所述的增稠剂包括卡拉胶4.8份、瓜尔胶5.6份、阿拉伯胶6份。
实施例2
一种用于高尿酸血症和痛风患者的医用营养粉,包含如下重量份的组份:蛋白质类物质316份、脂肪类物质240份、碳水化合物1180份、矿物质65份、维生素类物质23份、牛磺酸1.76份、单双甘油脂肪酸酯2.2份、左旋肉碱0.26份、增稠剂39.6份、香草香精4.5份、阿斯巴甜1.2份;
所述的蛋白质类物质包括乳清蛋白粉154份、大豆分离蛋白160份、全脂奶粉165份、牛初乳2.5份。
所述的脂肪类物质包括紫苏油粉19.1份、椰子油粉83.6份、大豆油粉220份、橄榄油粉83.6份、中链甘油三酯粉6.6份。
所述碳水化合物包括麦芽糊精682份、菊粉66份、抗性糊精230份。
所述的维生素类物质包括维生素A 0.14份、维生素D3 0.09份、维生素E 0.21份、维生素K1 0.019份、维生素B1 0.025份、维生素B2 0.03份、维生素B6 0.02份、维生素B120.004份、抗坏血酸钠3.2份、D-泛酸钙0.07份、叶酸0.005份、烟酰胺0.04份、氯化胆碱12份、D-生物素0.23份、肌醇7.5份。
所述的矿物质包括柠檬酸钙22份、L-乳酸钙24份、磷酸二氢钠25份、柠檬酸钠68份、葡萄糖酸镁50份、葡萄糖酸亚铁0.9份、葡萄糖酸锌1.1份、葡萄糖酸钾100份、亚硒酸钠0.003份、碘化钾0.0018份、无水硫酸铜0.06份、葡萄糖酸锰0.3份。
所述的增稠剂包括卡拉胶13.2份、瓜尔胶15.4份、阿拉伯胶11份。
实施例3:
一种用于高尿酸血症和痛风患者的医用营养粉,包含如下重量份的组份:蛋白质类物质503份、脂肪类物质379份、碳水化合物1876份、矿物质99.5份、维生素类物质29.4份、牛磺酸2.9份、单双甘油脂肪酸酯3.5份、左旋肉碱0.42份、增稠剂63份、香草香精7份、阿斯巴甜1.83份;
所述的蛋白质类物质包括乳清蛋白粉245份、大豆分离蛋白252份、全脂奶粉246份、牛初乳3.5份。
所述的脂肪类物质包括紫苏油粉30.5份、椰子油粉133份、大豆油粉360份、橄榄油粉140份、中链甘油三酯粉10.5份。
所述碳水化合物包括麦芽糊精1084份、菊粉105份、抗性糊精350份。
所述的维生素类物质包括维生素A 0.21份、维生素D3 0.14份、维生素E 0.32份、维生素K1 0.029份、维生素B1 0.035份、维生素B2 0.038份、维生素B60.04份、维生素B120.008份、抗坏血酸钠5.1份、D-泛酸钙0.11份、叶酸0.007份、烟酰胺0.08份、氯化胆碱17.5份、D-生物素0.032份、肌醇11.6份。
所述的矿物质包括柠檬酸钙35份、L-乳酸钙40份、磷酸二氢钠35份、柠檬酸钠105份、葡萄糖酸镁80.5份、葡萄糖酸亚铁1.4份、葡萄糖酸锌1.7份、葡萄糖酸钾157.5份、亚硒酸钠0.004份、碘化钾0.003份、无水硫酸铜0.09份、葡萄糖酸锰0.44份。
所述的增稠剂包括卡拉胶21份、瓜尔胶25份、阿拉伯胶17.5份。
实施例4:
根据实施例1中的一种用于高尿酸血症和痛风患者的医用营养粉的制备方法,包括以下步骤:
(1)准确称量原辅料
预混料a:包括上述的全部蛋白质类物质和部分碳水化合物;
预混料b:包括另一部分碳水化合物和全部矿物质;
预混料c:包括上述全部的脂肪类物质、单双甘油脂肪酸酯和增稠剂;
预混料d:包括剩余的碳水化合物、香草香精、阿斯巴甜、牛磺酸、左旋肉碱和全部维生素类物质;
(2)预混料a、b
将预混料a的原辅料转移至槽型混合机进行混合,搅拌时间为50min,得到预混料a;将预混料b的原辅料转移至方锥形混合机的混料斗中混合,调节转速为20r/min,最高/最低频率为50/5HZ,时间为50min,得到预混料b;然后再将预混料a、b投入槽型混合机中,反向搅拌50min,取出备用;
(3)制粒
使用高效湿法制粒机制软材,打开搅拌开关,调节转速为20r/min,搅拌5min;然后向预混料a、b中加入适量40%酒精粘合剂溶液500g,边搅拌边加浆,转速设置采用分段式,先设置搅拌速度为10r/min,分散10r/min,加入部分酒精,喷加酒精的频率为2s/次,每次喷加酒精10g,间隔5s,加入后搅拌5min;其次设置搅拌速度为20r/min,分散20r/min,再加入部分酒精,加入后搅拌5min;最后加入剩余的酒精,加入后搅拌5-20min,三次添加酒精的比例为2:3:1;
然后取100g样品过40目、80目和100目筛网查看颗粒分布,分布合适即可出料;
(4)干燥整粒
将湿颗粒均匀铺于烘盘中,然后置于60℃烘箱内进行烘干,当品水分至5%左右停止烘干,关闭烘箱开关,取出样品;
(5)预混料c、d
将预混料c的原辅料、和预混料d的原辅料投入混料斗中进行预混,设置转速40r/min,时间为50min,得到预混料c和预混料d;
(6)总混
称取与制粒样品等比例的预混料c、d倒入三维混合机中,再投入制粒样品,设置转速40r/min,混合100min,得到成品。
实施例5:
结合实施例2中的一种用于高尿酸血症和痛风患者的医用营养粉的制备方法,包括以下步骤:
(1)准确称量原辅料
预混料a:包括上述的全部蛋白质类物质和部分碳水化合物;
预混料b:包括另一部分碳水化合物和全部矿物质;
预混料c:包括上述全部的脂肪类物质、单双甘油脂肪酸酯和增稠剂;
预混料d:包括剩余的碳水化合物、香草香精、阿斯巴甜、牛磺酸、左旋肉碱和全部维生素类物质;
(2)预混料a、b
将预混料a的原辅料转移至槽型混合机进行混合,搅拌时间为80min,得到预混料a;将预混料b的原辅料转移至方锥形混合机的混料斗中混合,调节转速为30r/min,最高/最低频率为50/5HZ,时间为80min,得到预混料b;然后再将预混料a、b投入槽型混合机中,反向搅拌80min,取出备用;
(3)制粒
使用高效湿法制粒机制软材,打开搅拌开关,调节转速为30r/min,搅拌30min;然后向预混料a、b中加入适量40%酒精粘合剂溶液1200g,边搅拌边加浆,转速设置采用分段式,先设置搅拌速度为30r/min,分散20r/min,加入部分酒精,喷加酒精的频率为8s/次,每次喷加酒精30g,间隔10s,加入后搅拌15min;其次设置搅拌速度为50r/min,分散50r/min,再加入部分酒精,加入后搅拌5min;最后加入剩余的酒精,加入后搅拌20min,三次添加酒精的比例为2:3:1;
然后取100g样品过40目、80目和100目筛网查看颗粒分布,分布合适即可出料;
(4)干燥整粒
将湿颗粒均匀铺于烘盘中,然后置于60℃烘箱内进行烘干,当品水分至5%左右停止烘干,关闭烘箱开关,取出样品;
(5)预混料c、d
将预混料c的原辅料、和预混料d的原辅料投入混料斗中进行预混,设置转速50r/min,时间为80min,得到预混料c和预混料d;
(6)总混
称取与制粒样品等比例的预混料c、d倒入三维混合机中,再投入制粒样品,设置转速50r/min,混合150min,得到成品。
实施例6:
结合实施例3中的一种用于高尿酸血症和痛风患者的医用营养粉的制备方法,包括以下步骤:
(1)准确称量原辅料
预混料a:包括上述的全部蛋白质类物质和部分碳水化合物;
预混料b:包括另一部分碳水化合物和全部矿物质;
预混料c:包括上述全部的脂肪类物质、单双甘油脂肪酸酯和增稠剂;
预混料d:包括剩余的碳水化合物、香草香精、阿斯巴甜、牛磺酸、左旋肉碱和全部维生素类物质;
(2)预混料a、b
将预混料a的原辅料转移至槽型混合机进行混合,搅拌时间为70min,得到预混料a;将预混料b的原辅料转移至方锥形混合机的混料斗中混合,调节转速为25r/min,最高/最低频率为50/5HZ,时间为55min,得到预混料b;然后再将预混料a、b投入槽型混合机中,反向搅拌70min,取出备用;
(3)制粒
使用高效湿法制粒机制软材,打开搅拌开关,调节转速为23r/min,搅拌15min;然后向预混料a、b中加入适量40%酒精粘合剂溶液1000g,边搅拌边加浆,转速设置采用分段式,先设置搅拌速度为25r/min,分散10r/min,加入部分酒精,喷加酒精的频率为7s/次,每次喷加酒精15g,间隔9s,加入后搅拌13min;其次设置搅拌速度为45r/min,分散35r/min,再加入部分酒精,加入后搅拌5min;最后加入剩余的酒精,加入后搅拌15min,三次添加酒精的比例为2:3:1;
然后取100g样品过40目、80目和100目筛网查看颗粒分布,分布合适即可出料;
(4)干燥整粒
将湿颗粒均匀铺于烘盘中,然后置于60℃烘箱内进行烘干,当品水分至5%左右停止烘干,关闭烘箱开关,取出样品;
(5)预混料c、d
将预混料c的原辅料、和预混料d的原辅料投入混料斗中进行预混,设置转速50r/min,时间为55min,得到预混料c和预混料d;
(6)总混
称取与制粒样品等比例的预混料c、d倒入三维混合机中,再投入制粒样品,设置转速50r/min,混合125min,得到成品。
对于本领域技术人员而言,显然本发明不限于上述示范性实施例的细节,而且在不背离本发明的精神或基本特征的情况下,能够以其他的具体形式实现本发明。因此,无论从哪一点来看,均应将实施例看作是示范性的,而且是非限制性的,本发明的范围由所附权利要求而不是上述说明限定,因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。
Claims (7)
1.一种用于高尿酸血症和痛风患者的医用营养粉,其特征在于:包含如下重量份的组份:蛋白质类物质71.9-575份、脂肪类物质54-433份、碳水化合物268-2145份、矿物质14.2-114份、维生素类物质4-35份、牛磺酸0.4-3.2份、0.5-4份、左旋肉碱0.06-0.49份、增稠剂10-72份、香草香精1-8份、阿斯巴甜0.28-2.2份;所述的蛋白质类物质包括乳清蛋白粉35-280份、大豆分离蛋白30-280份、全脂奶粉35-275份、牛初乳0.4-4.0份。
2.根据权利要求1所述一种用于高尿酸血症和痛风患者的医用营养粉,其特征在于:所述的脂肪类物质包括紫苏籽油粉5-35份、椰子油粉19-152份、大豆油粉50-400份、橄榄油粉20-155份、中链甘油三酯粉1.5-12份。
3.根据权利要求1所述一种用于高尿酸血症和痛风患者的医用营养粉,其特征在于:所述碳水化合物包括麦芽糊精155-1240份、菊粉15-120份、抗性糊精50-400份。
4.根据权利要求1所述一种用于高尿酸血症和痛风患者的医用营养粉,其特征在于:所述的维生素类物质包括维生素A0.03-0.24份、维生素D30.02-0.16份、维生素E0.05-0.37份、维生素K10.004-0.032份、维生素B10.005-0.044份、维生素B20.006-0.04份、维生素B60.005-0.045份、维生素B120.001-0.009份、抗坏血酸钠0.74-5.8份、D-泛酸钙0.016-0.13份、叶酸0.001-0.008份、烟酰胺0.01-0.09份、氯化胆碱2.5-20份、D-生物素0.005-0.036份、肌醇1.65-13.2份。
5.根据权利要求1所述一种用于高尿酸血症和痛风患者的医用营养粉,其特征在于:所述的矿物质包括柠檬酸钙5-40份、L-乳酸钙4-45份、磷酸二氢钠5-40份、柠檬酸钠15-120份、葡萄糖酸镁11.5-93份、葡萄糖酸亚铁0.2-1.6份、葡萄糖酸锌0.25-1.96份、葡萄糖酸钾22.5-180份、亚硒酸钠0.0006-0.005份、碘化钾0.0004-0.0035份、无水硫酸铜0.013-0.1份、葡萄糖酸锰0.06-0.5份。
6.根据权利要求1所述一种用于高尿酸血症和痛风患者的医用营养粉,其特征在于:所述的增稠剂包括卡拉胶3-24份、瓜尔胶3.5-29份、阿拉伯胶2.5-20份。
7.一种如权利要求1-6中任意一条所述的用于高尿酸血症和痛风患者的医用营养粉的制备方法,其特征在于:包括以下步骤:
(1)准确称量原辅料
预混料a:包括上述的全部蛋白质类物质和部分碳水化合物;
预混料b:包括另一部分碳水化合物和全部矿物质;
预混料c:包括上述全部的脂肪类物质、单双甘油脂肪酸酯和增稠剂;
预混料d:包括剩余的碳水化合物、香草香精、阿斯巴甜、牛磺酸、左旋肉碱和全部维生素类物质;
(2)预混料a、b
将预混料a的原辅料转移至槽型混合机进行混合,搅拌时间为50-80min,得到预混料a;将预混料b的原辅料转移至方锥形混合机的混料斗中混合,调节转速为20-30r/min,最高/最低频率为50/5HZ,时间为50-80min,得到预混料b;然后再将预混料a、b投入槽型混合机中,反向搅拌50-80min,取出备用;
(3)制粒
使用高效湿法制粒机制软材,打开搅拌开关,调节转速为20-30r/min,搅拌5-30min;然后向预混料a、b中加入适量40%酒精粘合剂溶液,边搅拌边加浆。转速设置采用分段式,先设置搅拌速度为10-30r/min,分散速度10-30r/min,加入部分酒精,喷加酒精的频率为2-8s/次,每次约喷加酒精10~20g,间隔5-10s,加入后搅拌5-15min;其次设置搅拌速度为20-50r/min,分散速度20-50r/min,再加入部分酒精,加入后搅拌5-15min;最后加入剩余的酒精,加入后搅拌5-15min,三次添加酒精的比例为2:3:1;
然后取100g样品过40目、80目和100目筛网查看颗粒分布,分布合适即可出料;
(4)干燥整粒
将湿颗粒均匀铺于烘盘中,然后置于60℃烘箱内进行烘干,当品水分至5%左右停止烘干,关闭烘箱开关,取出样品;
(5)预混料c、d
将预混料c的原辅料、和预混料d的原辅料投入混料斗中进行预混,设置转速30-50r/min,时间为50-80min,得到预混料c和预混料d;
(6)总混
称取与制粒样品等比例的预混料c、d倒入三维混合机中,再投入制粒样品,设置转速30-50r/min,混合100-150min,得到成品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010046666.6A CN111387483A (zh) | 2020-01-16 | 2020-01-16 | 一种用于高尿酸血症和痛风患者的医用营养粉及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010046666.6A CN111387483A (zh) | 2020-01-16 | 2020-01-16 | 一种用于高尿酸血症和痛风患者的医用营养粉及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111387483A true CN111387483A (zh) | 2020-07-10 |
Family
ID=71410836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010046666.6A Withdrawn CN111387483A (zh) | 2020-01-16 | 2020-01-16 | 一种用于高尿酸血症和痛风患者的医用营养粉及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111387483A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114128894A (zh) * | 2021-05-26 | 2022-03-04 | 石药集团中诺药业(泰州)有限公司 | 一种用于高尿酸和痛风人群的降尿酸营养素组合物和制备方法 |
CN115177634A (zh) * | 2022-07-26 | 2022-10-14 | 武汉英纽林生物科技有限公司 | 一种抗痛风组合物及其制备方法与应用 |
-
2020
- 2020-01-16 CN CN202010046666.6A patent/CN111387483A/zh not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114128894A (zh) * | 2021-05-26 | 2022-03-04 | 石药集团中诺药业(泰州)有限公司 | 一种用于高尿酸和痛风人群的降尿酸营养素组合物和制备方法 |
CN115177634A (zh) * | 2022-07-26 | 2022-10-14 | 武汉英纽林生物科技有限公司 | 一种抗痛风组合物及其制备方法与应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111165801A (zh) | 一种用于骨病康复患者的医用营养粉及制备方法 | |
CN111387483A (zh) | 一种用于高尿酸血症和痛风患者的医用营养粉及制备方法 | |
KR20110135986A (ko) | 당뇨병 요법을 지원하기 위한 α-케토산을 포함하는 식이 보충제 | |
CN103431392B (zh) | 一种供糖尿病患者食用的复合海洋特膳食品 | |
CN111387487A (zh) | 一种用于肺病患者的特殊医学用途配方营养粉及制备方法 | |
AU2010212456B2 (en) | Formulas comprising calcium, magnesium, zinc, and vitamin D3, for the prevention and amelioration of osteoporosis | |
CN111387484A (zh) | 一种用于肌肉衰减症患者的医用营养粉及制备方法 | |
CN110742267B (zh) | 一种炎性肠病全营养配方食品 | |
CN110638043A (zh) | 一种富含益生菌的全营养配方食品及其制备方法与应用 | |
CN106165905B (zh) | 一种钙加维生素软胶囊及制备方法 | |
CN110637888A (zh) | 早产/低出生体重婴儿配方粉及其制备方法 | |
CN111165802A (zh) | 一种用于肾病非透析患者的医用营养粉及制备方法 | |
CN105878397A (zh) | 一种调节牛羊运输应激组合物 | |
CN105106217A (zh) | 一种孕妇营养补充剂及其制备方法 | |
CN100360139C (zh) | 排铅助长片及其制备方法 | |
CN111387486A (zh) | 用于肝病患者的特殊医学用途配方营养粉及其制备方法 | |
CN111165805A (zh) | 用于脂肪类物质代谢异常患者的医用营养粉及制备方法 | |
CN111387485A (zh) | 一种用于慢性胰腺炎患者的医用营养粉及制备方法 | |
CN110214938A (zh) | 用于糖尿病人群的特殊医学用途配方营养粉及其制备方法 | |
CN103445168B (zh) | 复合海参颗粒咀嚼片及其制备方法 | |
CN103404875B (zh) | 一种供心血管疾病患者食用的复合海洋特膳食品 | |
CN111165803A (zh) | 一种用于高血压患者的医用营养粉及制备方法 | |
CN102106467A (zh) | 降低鸡蛋中胆固醇含量的饲料添加剂及其制备方法 | |
CN104738623A (zh) | 一种富含维生素k2和钙剂的香菇粉胶囊及其制备方法 | |
CN110742266B (zh) | 一种辅助调节肠道免疫功能的全营养配方食品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: No.138, South Zhaoyang Road, Rizhao Economic Development Zone, Shandong Province Applicant after: Tekang Pharmaceutical Group Co.,Ltd. Address before: 276800 no.382, Dalian Road, Rizhao Economic Development Zone, Shandong Province (300m west of the intersection of Lanzhou road and Dalian Road) Applicant before: Shandong Tekang Pharmaceutical Co.,Ltd. |
|
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20200710 |